Literature DB >> 23096745

[Posterior reversible encephalopathy syndrome: description of a case in the setting of severe infection].

Pio Zeppa1, Paolo Fonio, Melchiore Giganti, Antonio Raffaele Cotroneo, Eugenio Annibale Genovese, Antonio Amato Stabile Ianora.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a well recognized neurotoxic state coupled with a unique neuroradiological appearance. This syndrome is associated with a broad spectrum of complex conditions (preeclampsia/eclampsia, bone marrow/organ transplantation, chemotherapy, autoimmune disease). We report the case of a female patient who developed PRES in the setting of severe infection, and we discuss the possible mechanisms underlying the development of cerebral edema by describing the inherent neuroradiological features.

Entities:  

Mesh:

Year:  2012        PMID: 23096745     DOI: 10.1701/1166.12902

Source DB:  PubMed          Journal:  Recenti Prog Med        ISSN: 0034-1193


  3 in total

1.  VFMSS findings in elderly dysphagic patients: our experience.

Authors:  Alfonso Reginelli; Francesca Iacobellis; Lucia Del Vecchio; Luigi Monaco; Daniela Berritto; Graziella Di Grezia; Eugenio Genovese; Melchiore Giganti; Salvatore Cappabianca
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

2.  A study on clinical and radiological features and outcome in patients with posterior reversible encephalopathy syndrome (PRES).

Authors:  Rahul R Singh; Nurdan Ozyilmaz; Simon Waller; Jean-Marie U-King-Im; Ming Lim; Ata Siddiqui; Manish D Sinha
Journal:  Eur J Pediatr       Date:  2014-04-16       Impact factor: 3.183

3.  How the preoperative ultrasound examination and BFI of the cervical lymph nodes modify the therapeutic treatment in patients with papillary thyroid cancer.

Authors:  Giuseppina Napolitano; Antonio Romeo; Gianfranco Vallone; Michele Rossi; Luca Cagini; Gabriele Antinolfi; Mario Vitale; Luca Brunese; Eugenio Genovese
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.